JP2018520170A5 - - Google Patents

Download PDF

Info

Publication number
JP2018520170A5
JP2018520170A5 JP2018500737A JP2018500737A JP2018520170A5 JP 2018520170 A5 JP2018520170 A5 JP 2018520170A5 JP 2018500737 A JP2018500737 A JP 2018500737A JP 2018500737 A JP2018500737 A JP 2018500737A JP 2018520170 A5 JP2018520170 A5 JP 2018520170A5
Authority
JP
Japan
Prior art keywords
pyrrolo
pyridin
ethanone
methyl
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018500737A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018520170A (ja
JP6964576B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/041339 external-priority patent/WO2017007938A1/en
Publication of JP2018520170A publication Critical patent/JP2018520170A/ja
Publication of JP2018520170A5 publication Critical patent/JP2018520170A5/ja
Priority to JP2021138906A priority Critical patent/JP7369743B2/ja
Application granted granted Critical
Publication of JP6964576B2 publication Critical patent/JP6964576B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018500737A 2015-07-09 2016-07-07 置換4−アザインドール及びglun2b受容体調節因子としてのそれらの使用 Active JP6964576B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021138906A JP7369743B2 (ja) 2015-07-09 2021-08-27 置換4-アザインドール及びglun2b受容体調節因子としてのそれらの使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562190416P 2015-07-09 2015-07-09
US62/190,416 2015-07-09
PCT/US2016/041339 WO2017007938A1 (en) 2015-07-09 2016-07-07 Substituted 4-azaindoles and their use as glun2b receptor modulators

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021138906A Division JP7369743B2 (ja) 2015-07-09 2021-08-27 置換4-アザインドール及びglun2b受容体調節因子としてのそれらの使用

Publications (3)

Publication Number Publication Date
JP2018520170A JP2018520170A (ja) 2018-07-26
JP2018520170A5 true JP2018520170A5 (enExample) 2019-07-25
JP6964576B2 JP6964576B2 (ja) 2021-11-10

Family

ID=56497884

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018500737A Active JP6964576B2 (ja) 2015-07-09 2016-07-07 置換4−アザインドール及びglun2b受容体調節因子としてのそれらの使用
JP2021138906A Active JP7369743B2 (ja) 2015-07-09 2021-08-27 置換4-アザインドール及びglun2b受容体調節因子としてのそれらの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021138906A Active JP7369743B2 (ja) 2015-07-09 2021-08-27 置換4-アザインドール及びglun2b受容体調節因子としてのそれらの使用

Country Status (25)

Country Link
US (2) US9963447B2 (enExample)
EP (1) EP3319963B1 (enExample)
JP (2) JP6964576B2 (enExample)
KR (1) KR20180026760A (enExample)
CN (1) CN108026094B (enExample)
AU (1) AU2016291158B2 (enExample)
BR (1) BR112018000468A2 (enExample)
CA (1) CA2991765C (enExample)
CY (1) CY1123007T1 (enExample)
DK (1) DK3319963T3 (enExample)
EA (1) EA033197B1 (enExample)
ES (1) ES2781867T3 (enExample)
HR (1) HRP20200410T1 (enExample)
HU (1) HUE047460T2 (enExample)
IL (1) IL256758A (enExample)
LT (1) LT3319963T (enExample)
MA (1) MA42397B1 (enExample)
MD (1) MD3319963T2 (enExample)
MX (1) MX2018000352A (enExample)
PL (1) PL3319963T3 (enExample)
PT (1) PT3319963T (enExample)
SI (1) SI3319963T1 (enExample)
SM (1) SMT202000134T1 (enExample)
WO (1) WO2017007938A1 (enExample)
ZA (1) ZA201800827B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016025918A1 (en) 2014-08-15 2016-02-18 Janssen Pharmaceuticals, Inc. Pyrazoles
JP6605020B2 (ja) 2014-08-15 2019-11-13 ヤンセン ファーマシューティカルズ,インコーポレーテッド Nr2b受容体阻害剤としてのトリアゾール
BR112018000468A2 (pt) * 2015-07-09 2018-09-18 Janssen Pharmaceutica Nv 4-azaindóis substituídos e seu uso como moduladores do receptor de glun2b
JP6923543B2 (ja) 2016-02-10 2021-08-18 ヤンセン ファーマシューティカ エヌ.ベー. Nr2b選択的nmda調節因子としての置換1,2,3−トリアゾール
TW201819376A (zh) 2016-10-06 2018-06-01 比利時商健生藥品公司 經取代之1H-咪唑並[4,5-b]吡啶-2(3H)-酮及其作為GLUN2B受體調節劑之用途
US11008302B2 (en) 2018-04-04 2021-05-18 Janssen Pharmaceutica Nv Substituted pyridine and pyrimidines and their use as GluN2B receptor modulators
BR112021023562A2 (pt) 2019-06-14 2022-01-04 Janssen Pharmaceutica Nv Carbamatos de pirazina e seus usos como moduladores do receptor de glun2b
JP7667097B2 (ja) * 2019-06-14 2025-04-22 ヤンセン ファーマシューティカ エヌ.ベー. 置換ピラゾロ-ピリジンアミド及びglun2b受容体調節因子としてのその使用
US11161846B2 (en) 2019-06-14 2021-11-02 Janssen Pharmaceutica Nv Substituted pyrazolo[4,3-b]pyridines and their use as GluN2B receptor modulators
BR112021025141A2 (pt) 2019-06-14 2022-01-25 Janssen Pharmaceutica Nv Pirazolo-piridinas heteroaromáticas substituídas e seu uso como moduladores do receptor glun2b
WO2020249792A1 (en) * 2019-06-14 2020-12-17 Janssen Pharmaceutica Nv Substituted pyrazolo-pyridine amides and their use as glun2b receptor modulators
CA3143105A1 (en) 2019-06-14 2020-12-17 Janssen Pharmaceutica Nv Substituted pyrazolo-pyrazines and their use as glun2b receptor modulators
BR112021025132A2 (pt) 2019-06-14 2022-01-25 Janssen Pharmaceutica Nv Carbamatos de piridina e seu uso como moduladores do receptor glun2b
CN114621125B (zh) * 2020-12-14 2024-07-09 中国科学技术大学 Nlrp3炎症小体抑制剂及其应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7534800B2 (en) * 2002-03-28 2009-05-19 Eisai R & D Development Co., Ltd. 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders
JP2007523178A (ja) 2004-02-18 2007-08-16 アストラゼネカ アクチボラグ 代謝型グルタメート受容体アンタゴニストとしてのトリアゾール化合物およびそれらの使用
US20060183758A1 (en) * 2005-02-17 2006-08-17 Cb Research And Development, Inc. Method for synthesis of AZA-annelated pyrroles, thiophenes, and furans
US7807704B2 (en) * 2006-03-30 2010-10-05 Chemocentryx, Inc. Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2
PE20090717A1 (es) * 2007-05-18 2009-07-18 Smithkline Beecham Corp Derivados de quinolina como inhibidores de la pi3 quinasa
MX2009012749A (es) 2007-05-25 2010-03-10 Abbott Gmbh & Co Kg Compuestos heterociclicos como moduladores positivos del receptor de glutamato metabotropico 2 (receptor mglu2).
US20100325949A1 (en) 2007-07-03 2010-12-30 Edward Scott Carlson Support apparatus for climbing plants
CN101842357A (zh) 2007-08-30 2010-09-22 武田药品工业株式会社 取代的吡唑衍生物
WO2009058261A1 (en) 2007-10-31 2009-05-07 Merck & Co., Inc. Modulation of sleep with nr2b receptor antagonists
NZ588698A (en) 2008-03-27 2012-06-29 Evotec Neurosciences Gmbh Methods for treating disorders using nmda nr2b-subtype selective antagonist
ES2459047T3 (es) 2008-08-05 2014-05-07 Daiichi Sankyo Company, Limited Derivados de imidazopiridin-2-ona
RU2517181C2 (ru) * 2008-10-16 2014-05-27 Орто-Макнейл-Янссен Фармасьютикалз, Инк. Производные индола и бензоморфолина в качестве модулятора метаботропных глутаматных рецепторов
EP3037421A3 (en) 2008-11-25 2016-11-30 University Of Rochester Mlk inhibitors and methods of use
TWI625121B (zh) * 2009-07-13 2018-06-01 基利科學股份有限公司 調節細胞凋亡信號之激酶的抑制劑
WO2011156245A2 (en) 2010-06-09 2011-12-15 Merck Sharp & Dohme Corp. Positive allosteric modulators of mglur2
WO2013130855A1 (en) 2012-03-02 2013-09-06 Takeda Pharmaceutical Company Limited Indazole derivatives
WO2014124651A1 (en) * 2013-02-15 2014-08-21 Københavns Universitet Pyrrolidine-2-carboxylic acid derivatives as iglur antagonists
JP2016516710A (ja) * 2013-03-13 2016-06-09 アッヴィ・インコーポレイテッド ピリジン系cdk9キナーゼ阻害薬
SMT201800650T1 (it) * 2013-03-15 2019-01-11 Plexxikon Inc Composti eterociclici e loro impiego
CN103626767A (zh) * 2013-12-04 2014-03-12 上海药明康德新药开发有限公司 区域选择性的氮杂吲哚及其合成方法
WO2016025918A1 (en) 2014-08-15 2016-02-18 Janssen Pharmaceuticals, Inc. Pyrazoles
JP6605020B2 (ja) 2014-08-15 2019-11-13 ヤンセン ファーマシューティカルズ,インコーポレーテッド Nr2b受容体阻害剤としてのトリアゾール
BR112018000468A2 (pt) 2015-07-09 2018-09-18 Janssen Pharmaceutica Nv 4-azaindóis substituídos e seu uso como moduladores do receptor de glun2b
JP6923543B2 (ja) 2016-02-10 2021-08-18 ヤンセン ファーマシューティカ エヌ.ベー. Nr2b選択的nmda調節因子としての置換1,2,3−トリアゾール
TW201819376A (zh) 2016-10-06 2018-06-01 比利時商健生藥品公司 經取代之1H-咪唑並[4,5-b]吡啶-2(3H)-酮及其作為GLUN2B受體調節劑之用途

Similar Documents

Publication Publication Date Title
JP2018520170A5 (enExample)
HRP20200410T1 (hr) Supstituirani 4-azaindoli i njihova upotreba kao modulatora glun2b receptora
JP2019530695A5 (enExample)
JP7308220B2 (ja) オキサジンモノアシルグリセロールリパーゼ(magl)阻害剤
JP2016523911A5 (enExample)
JP2011500806A5 (enExample)
CN1902196B (zh) 噻唑衍生物
JP7609854B2 (ja) Magl阻害剤としての4,4a,5,7,8,8a-ヘキサピリド[4,3-b][1,4]オキサジン-3-オン化合物
JP2021533093A (ja) モノアシルグリセロールリパーゼ阻害剤としての新規複素環化合物
JP2016519156A5 (enExample)
JP2017502049A5 (enExample)
CN116531380A (zh) 用于治疗癌症的2-杂芳基-3-氧代-2,3-二氢哒嗪-4-甲酰胺
RU2021133444A (ru) Производные бензимидазола в качестве модуляторов ror-гамма
CN107624111A (zh) 作为激酶抑制剂的杂环酰胺
CN104024250B (zh) 作为痕量胺相关受体(taar)的杂环衍生物
US9809573B2 (en) Substituted pyridine derivatives useful as GSK-3 inhibitors
JP2016523925A5 (enExample)
JP2019523233A5 (enExample)
IL263511A (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
JP2017500364A5 (enExample)
JP2017528515A5 (enExample)
RU2016112952A (ru) Производные индола и индазола
JP2020503302A5 (enExample)
JP6255516B2 (ja) モルホリン−ピリジン誘導体
JPWO2020249791A5 (enExample)